These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 10213939)

  • 21. [A method for distinguishing infected from vaccinated pigs as a basis for the control of Aujeszky's disease].
    van Oirschot JT
    Tijdschr Diergeneeskd; 1988 Jan; 113(1):19-27. PubMed ID: 2829384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression and purification of Suid Herpesvirus-1 glycoprotein E in the baculovirus system and its use to diagnose Aujeszky's disease in infected pigs.
    Serena MS; Geisler C; Metz GE; Corva SG; Mórtola EC; Larsen A; Jarvis DL; Echeverría MG
    Protein Expr Purif; 2013 Jul; 90(1):1-8. PubMed ID: 23631926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isolation of mutants of Aujeszky's disease virus with antigenically altered glycoprotein E by affinity chromatography using monoclonal antibodies.
    Morenkov OS; Smirnov SV; Vrublevskaya VV
    J Virol Methods; 1999 Jan; 77(1):101-8. PubMed ID: 10029330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A differential ELISA based on recombinant immunodominant epitopes of the gE gene of SHV-1 in a baculovirus-insect cell system to discriminate between pigs infected naturally with pseudorabies and vaccinated pigs.
    Serena MS; Metz GE; Corva SG; Mórtola EC; Echeverría MG
    J Virol Methods; 2011 Feb; 171(2):388-93. PubMed ID: 21168443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aujeszky's disease vaccination and differentiation of vaccinated from infected pigs.
    Pensaert M; Labarque G; Favoreel H; Nauwynck H
    Dev Biol (Basel); 2004; 119():243-54. PubMed ID: 15742635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of three glycoprotein-I ELISAs for Aujeszky's disease virus.
    Motha MX; Eernisse KA
    Vet Rec; 1992 Jun; 130(24):539-40. PubMed ID: 1332240
    [No Abstract]   [Full Text] [Related]  

  • 27. Field trial to evaluate the immunogenicity of pseudorabies virus vaccines with deletions for glycoproteins G and E.
    Firkins LD; Weigel RM; Biehl LG; Hahn EC
    Am J Vet Res; 1997 Sep; 58(9):976-84. PubMed ID: 9285001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A highly specific and sensitive sandwich blocking ELISA based on baculovirus expressed pseudorabies virus glycoprotein B.
    Gut-Winiarska M; Jacobs L; Kerstens H; Bienkowska-Szewczyk K
    J Virol Methods; 2000 Jul; 88(1):63-71. PubMed ID: 10921843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of colostrum to detect antibodies against glycoprotein I of Aujeszky's disease virus.
    Bouwkamp FT; Stegeman JA; Kimman TG
    Vet Rec; 1993 Dec; 133(24):591-3. PubMed ID: 8116169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differentiation of serum antibodies from pigs vaccinated or infected with Aujeszky's disease virus by a competitive enzyme immunoassay.
    van Oirschot JT; Rziha HJ; Moonen PJ; Pol JM; van Zaane D
    J Gen Virol; 1986 Jun; 67 ( Pt 6)():1179-82. PubMed ID: 3011974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Production of a baculovirus-derived gp50 protein and utilization in a competitive enzyme-linked immunosorbent assay for the serodiagnosis of pseudorabies virus.
    Prud'homme I; Zhou EM; Traykova M; Trotter H; Chan M; Afshar A; Harding MJ
    Can J Vet Res; 1997 Oct; 61(4):286-91. PubMed ID: 9342453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of tests for detection of antibodies to Aujeszky's disease (pseudorabies) virus glycoprotein E in the target population.
    Stegeman A; De Jong MC; Van der Heijden HM; Elbers AR; Kimman TG
    Vet Microbiol; 1997 Apr; 55(1-4):107-11. PubMed ID: 9220602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Epizoologic studies of the detection of antibodies against Aujeszky's disease virus in sera and blood eluates of swine from Thailand using ELISA ("Enzygnost," Behring), serum neutralization test and "Aujeszky Latex Kit" (Iffa Merieux)].
    Leamcharaskul P; Renner-Müller IC; Munz E; Reimann M
    Zentralbl Veterinarmed B; 1990 Aug; 37(6):418-29. PubMed ID: 2169687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycoprotein B of Aujeszky's disease virus: topographical epitope mapping and epitope-specific antibody response.
    Zaripov MM; Morenkov OS; Siklodi B; Barna-Vetro I; Gyöngyösi-Horvath A; Fodor I
    Res Virol; 1998; 149(1):29-41. PubMed ID: 9561562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of pseudorabies virus gE epitopes in Pichia pastoris and its utilization in an indirect PRV gE-ELISA.
    Ao JQ; Wang JW; Chen XH; Wang XZ; Long QX
    J Virol Methods; 2003 Dec; 114(2):145-50. PubMed ID: 14625049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Immunological characteristics of Aujeszky's disease virus glycoprotein].
    Vrublevskaia VV; Musienko VS; Skarga IuIu; Morenkov OS
    Vopr Virusol; 2007; 52(3):33-7. PubMed ID: 17601050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Constancy of Aujeszky's field virus antibody titres in sows repeatedly vaccinated with a gI-negative vaccine.
    Hopp W; Jungblut R
    Acta Vet Hung; 1994; 42(2-3):409-11. PubMed ID: 7810439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of specific humoral immune response in pigs vaccinated intradermally with deleted Aujeszky's disease vaccine and challenged with virulent strain of Herpesvirus suis type 1.
    Mikulska-Skupień E; Szweda W; Procajło Z
    Pol J Vet Sci; 2005; 8(1):11-6. PubMed ID: 15794468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a latex agglutination test using the major epitope domain of glycoprotein E of pseudorabies virus expressed in E. coli to differentiate between immune responses in pigs naturally infected or vaccinated with pseudorabies virus.
    Yong T; Huan-chun C; Shao-bo X; Ya-li Q; Qi-gai H; Yu-qi R
    Vet Res Commun; 2005 Aug; 29(6):487-97. PubMed ID: 16215839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety of an Aujeszky's disease vaccine based on deletion mutant strain 783 which does not express thymidine kinase and glycoprotein I.
    van Oirschot JT; Terpstra C; Moormann RJ; Berns AJ; Gielkens AL
    Vet Rec; 1990 Nov; 127(18):443-6. PubMed ID: 2177288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.